|
Prevention/Epidemiology Experts Discuss Impact of New Vaccines on Global HealthJune 9, 2011 This Malaria Policy Center blog post describes the event "Spurring health and wealth through medical breakthroughs," during which Washington Post columnist and ONE Fellow Michael Gerson; John Lusingu, principal research scientist at the Tanzania National Institute for Medical Research and co-principal investigator in the RTS,S malaria vaccine trial in Tanzania for the PATH Malaria Vaccine Initiative; and Margaret McGlynn, board member of the International AIDS Vaccine Initiative and former president of Merck Global Vaccines and Anti-Infectives, "brought unique perspectives to the impact of new vaccines on many global health issues, particularly HIV/AIDS and malaria" (Todd, 6/8). Back to other news for June 2011
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|